Mackay Shields LLC Moderna, Inc. Transaction History

Mackay Shields LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$117.13 - $176.59 $5.94 Million - $8.95 Million	-50,705 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $251,908 - $468,219	-1,992 Reduced 3.78%	50,705 $8.73 Million
Q4 2021 Feb 04, 2022	SELL	$225.82 - $368.51 $218,142 - $355,980	-966 Reduced 1.8%	52,697 $13.4 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $11.9 Million - $26 Million	53,663 New	53,663 $20.7 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $4.82 Million - $8.71 Million	-37,076 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $1.59 Million - $2.7 Million	-14,526 Reduced 28.15%	37,076 $4.86 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $314,105 - $811,591	-4,778 Reduced 8.47%	51,602 $5.39 Million
Q3 2020 Nov 04, 2020	BUY	$54.34 - $94.85 $81,020 - $141,421	1,491 Added 2.72%	56,380 $3.99 Million
Q2 2020 Jul 31, 2020	BUY	$29.67 - $80.0 $1.63 Million - $4.39 Million	54,889 New	54,889 $3.52 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.